In pregnant women testing negative for HIV, second-trimester preexposure prophylaxis with the dapivirine vaginal ring or oral tenofovir disoproxil fumarate-emtricitabine is safe.

If the source person's HIV screening test result is negative but there has been a risk for HIV exposure in the previous 6 weeks, plasma HIV RNA testing of the source person is also recommended. In ...

"When newborns aren't getting preventive treatment, it suggests we may be missing HIV infections in pregnant women." HealthDay News — Although the rate of perinatal HIV infection is low, more than 50% ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...

Please provide your email address to receive an email when new articles are posted on . SEATTLE — A monthly dapivirine vaginal ring, used by women as HIV prophylaxis, is safe for breastfeeding babies, ...

Persons initiating nPEP should be informed that preexposure prophylaxis (PrEP) can reduce their risk for acquiring HIV in the case of repeat or continuing exposure after the nPEP course. HealthDay ...

HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...

Local health officials report a decline in HIV prevalence, with new cases dropping below 200. The Women's Collective plays a ...

HealthDay News — Although the rate of perinatal HIV infection is low, more than 50% of HIV infections in infants before age 1 year occurred in those who did not receive postnatal prophylaxis, ...